Ingredion slashes earnings outlook on Argo plant disruption
Production failures and a thermal event at the Illinois sweetener facility forced the company to cut full-year guidance by five to seven percent.

Production failures and a thermal event at the Illinois sweetener facility forced the company to cut full-year guidance by five to seven percent.


Strong demand in India and emerging markets powered growth, though Middle East headwinds and crude costs pressured results.

The protein shakes maker cut its full-year forecasts as consumer price sensitivity and heavy promotions eroded margins despite modest revenue growth.

A new Earth Action study reveals packaging design and manufacturing processes are major sources of microplastic migration into food and beverages.

The meat supplier, formerly Miami Beef, secures private-equity backing as it expands into premium protein categories and adds production capacity.

The New Zealand fruit company is divesting regional fresh produce businesses to focus on apples and IP-driven fruit varieties.

The Danish cakes and biscuit maker adds the Irish bakery to its portfolio, gaining entry to major UK and Irish retailers and expanding its geographic reach.

Heineken Q1 2026 trading update (April 23, 2026): revenue +2.2% to ~£6.8B, net revenue +2.8%, net revenue per hectolitre +3.0%. Premium volume grew 5.8% led by the Heineken brand at +6.9%. Low and no-alcohol grew double digits. UK delivered volume growth in Europe alongside France and Spain. Heineken gained or held share in ~60% of markets. FY outlook 2 to 6% organic profit growth maintained.

Diageo H1 FY26 (six months ended 31 December 2025): net sales $10.5B with organic net sales -2.8%. Guinness was the standout: +10.9% globally with growth in every region except Asia Pacific. Great Britain +2.9% led by Guinness. Diageo confirmed Guinness as UK's number-one beer and Guinness 0.0 as UK's number-one alcohol-free beer. Non-alcoholic sales group-wide +14%.

Haleon Q1 2026 group organic revenue growth was 2.2%. Pain Relief came in essentially flat at -0.3% organic on £654m. Within Pain, Advil outperformed in North America driven by the No Pain More Gain campaign; Voltaren and Panadol grew in select geographies. Oral Health was the group-level standout. FY outlook reaffirmed.

Reckitt held Q1 2026 trading update on April 22, 2026 with Core LFL net revenue growth of 1.3% (3.1% excluding seasonal OTC). Emerging Markets grew 7.6% LFL to £1,087m. Mead Johnson Nutrition fell 2.7% LFL. FY 2026 guidance reaffirmed at 4 to 5% Core LFL. £1 billion share buyback continues with £669m completed by April 17.

Nestle has agreed to sell Blue Bottle Coffee to Centurium Capital, with the deal expected to close in H1 2026. The price was undisclosed but reported below the $425 million Nestle paid for the brand less than a decade ago. Nespresso-compatible pod rights stay with Nestle.

Mondelez held Q1 2026 results on April 29 with 6.3% organic group growth (developed markets at 0.8%). CEO Van de Put characterized European consumer confidence as stable but fragile. Cocoa cost partially offset top-line, but the mid-year crop is described as quite positive. FY 2026 guidance reaffirmed at flat to +2% topline.

Associated British Foods is separating its food business from Primark retail. Simon Harvey at Just-Food walks the key takeaways: how the food business was being valued inside the conglomerate, and what the standalone operator looks like.

FY 2025 sales of €27.3 billion, up 4.5% like-for-like. Volume/mix +2.7% finally outpaces pricing +1.8%, the first European data point showing the mix engine has taken over from the rate engine.